COVID-19

woman walks at UT Health San Antonio wearing a mask.

Message from the President: Announcement about delta variant and masks

July 20, 2021

We at UT Health San Antonio are closely monitoring the recent increase in community prevalence and transmission of the COVID-19 virus. At present, elsewhere and here in San Antonio, the latest surge is predominantly related to spread by the COVID delta variant. The delta variant is about four times more contagious than the original alpha variant and two times more lethal for unvaccinated people. Given the marked increase in community prevalence and spread, it is prudent that we increase our preventive protocols so that we can continue to keep on-campus transmission rates low.



Microscope in laboratory

UT Health San Antonio scientists continue relentless fight against COVID-19

June 28, 2021

Our biochemistry team learns more about how the coronavirus disguises itself in the body.



UT Healthier campaign sign at the San Antonio International Airport.

Traveling in a pandemic and the resumption of international business travel

June 23, 2021

By Chris Fuglestad, MFS, Office of International Services UT Health San Antonio international business will be considered again starting July 1. International business travel plays an integral role in the university’s mission to make lives better, and for many faculty members, the coronavirus pandemic brought international collaboration to an abrupt halt. But for Gabriel de Erausquin, MD, […]



WebMD: Help avoid COVID, injury as kids return to sports

June 22, 2021

Dr. Caitlyn Mooney, MD, Orthopaedics & Pediatrics, contributed to a Web MD story that speaks to the caution that needs to be taken as young athletes, once again, take to the fields, courts, tracks and rinks after such a long period away from such athletics due to restrictions of the pandemic; doctors are seeing more […]



In JAMA Oncology: Convalescent plasma improves survival in COVID-19 patients with blood cancers

June 17, 2021

Convalescent plasma therapy was associated with better survival in blood cancer patients hospitalized with COVID-19, especially in sicker patients. The findings by the COVID-19 and Cancer Consortium (CCC19) are newly published in the peer-reviewed journal JAMA Oncology.



injecting injection vaccine vaccination medicine flu woman docto

Novavax vaccine is highly protective against COVID-19 in Phase 3 results

June 17, 2021

UT Health San Antonio collaborated with University Health as part of the international COVID-19 Prevention Network and enrolled 176 Novavax clinical trial participants in San Antonio for the Phase 3 study, which is called PREVENT-19.